Moderna announced on May 12 that it will supply 25 million doses of its COVID-19 vaccine to Australia in a new deal with the government.
According to a statement from the American pharmaceutical company, the new supply agreement includes 10 million doses of the its original COVID-19 vaccine against the “ancestral strain” to be delivered this year.
The deal also includes 15 million doses of Moderna’s “updated variant booster candidate vaccine” to be delivered in 2022.
The deal for the doses is subject to regulatory approval by the Therapeutic Goods Administration of Australia. Moderna said it would submit an application “shortly.”
“We appreciate the partnership and support from the government of Australia with this first supply agreement for doses of the Moderna COVID-19 vaccine and our variant booster candidates,” Chief Executive Stéphane Bancel said in the statement.
Moderna also said in the statement that it has plans to open a commercial subsidiary in Australia this year to produce the vaccine locally.
“As we seek to protect people around the world with our COVID-19 vaccine and potentially our variant booster candidates, we look forward to continuing discussions with Australia about establishing potential local manufacturing opportunities,” Bancel stated.
Moderna has not yet been approved in Australia, but several other countries have rolled it out for use in adults.
Australia currently has two COVID-19 vaccines provisionally approved — one developed by Pfizer-BioNTech, which is eligible for those aged 16 years and older, and the other developed by AstraZeneca, which is eligible for those aged 18 years and older.
According to data from the Department of Health of Australia, over 2.8 million doses of the COVID-19 vaccines have been administered nationwide.
Data also showed that Australia has recorded 29,947 cases and 910 deaths since the beginning of the pandemic.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.